Announcements

Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
The Reagan-Udall Foundation for the FDA invites nominations for its annual Innovations in Regulatory Science & Policy Awards.

Coverage

The regulatory picture changed in February 2024, when the FDA held a Reagan-Udall Foundation forum on neuronopathic mucopolysaccharidoses.
On Wednesday, September 9, 2026, the author spoke briefly at a hybrid conference conducted by the Reagan-Udall Foundation for the U.S. Food and Drug Administration in Washington, D.C.
The Reagan-Udall Foundation for the FDA and FDA are also co-hosting a hybrid meeting on 16 October to discuss where the patient voice is needed in the rare disease product development timeline, its impact, and opportunities for patients to engage in the…